Alex
Rolland, BSc (Honours with distinction) Molecular/Cell Biology
Co-founder and Chief Research Director
Precision Oncology expert and Molecular Oncology Scientist, Alex Rolland, is the CEO and co-founder of Cancer Treatment Options and Management. As Chief Research Director, Alex conducts personalized research, facilitates tests, consults on treatment options, monitors treatment plans, and advocates directly for his clients. Alex is passionate about ensuring that anyone who receives a cancer diagnosis has access to the most effective, and least invasive, form of treatment possible.
Alex holds a BSc in Molecular/Cell Biology from the University of Victoria, and completed his PhD studies in Medical Genetics at the renowned Terry Fox Laboratory in Vancouver (BC Cancer Agency). He’s used his expertise to consult oncologists at the Mayo Clinic and other leading cancer treatment centers.
With over a decade of experience researching, consulting, and advocating for cancer patients, Alex also works directly with the medical system to explore the newest optimal treatments for his clients. He’s an expert in discovering how to optimize your cancer treatment, and making this a reality for you.
Discover more about Alex, including his educational background and professional experience in the field of cancer research.
You’ll also learn what inspired him to leave the lab, as well as his coveted teaching role, and to dedicate his life to helping cancer patients gain rapid access to the most effective treatments for their cancer. Alex is committed to changing the face of cancer care in Canada and throughout the world. His goal is to ensure that the CTOAM approach to cancer care becomes the standard of care, everywhere.
Noushin Moshgabadi
Research scientist Noushin Moshgabadi loves helping connect people with better healthcare and cancer treatment through her work in medical science.
Originally from Iran, Noushin has been living in British Columbia, Canada, for more than 15 years where she has studied and worked in scientific research for more than a decade. She obtained her Bachelors of Science in Cell & Molecular Biology from Vancouver’s Simon Fraser University (SFU); and her Masters of Science in Genetics, as well as her secondary Masters of Science, from the University of British Columbia’s Medical Genetics department (UBC).
Noushin has worked as a research scientist at Public Health Agency of Canada (PHAC), UBC hospitals, the Vancouver Prostate Centre (VPC), and several Genetics and Molecular Biology laboratories at both Simon Fraser University and the University of British Columbia.
In addition to her passion for genetics, molecular biology, and scientific research, Noushin enjoys exploring Vancouver’s beautiful natural landscape and hanging out with friends and family. She loves outdoor activities and can often be found doing different outdoor sports, like skiing, hiking, biking, sailing, and jogging.
Noushin is excited to be a part of the CTOAM team and working with cutting-edge experts who are leading the way in cancer care. Her life goal is to help people through medical science – and she feels that CTOAM provides her with an opportunity to make this dream come true.
Dr. Saima Paracha, MD
Bioinformatics Specialist
Saima is a graduate of the Medical Sciences program from Dow University of Health Sciences in Pakistan. She has completed a post graduate diploma program in Public Health Data Analysis from University of Victoria and has worked as a Physician Assistant and Research Assistant in different specialties for several years.
Saima has seen many people in her life affected by cancer and is dedicated to helping others with cancer get the right treatment. She knows how effective Precision Cancer Medicine is – that it offers a way to help eliminate cancer faster and with reduced side-effects, which is why she is passionate about her work with CTOAM.
She is inspired by new medical technologies and advancements in medicine. Ultimately Saima is motivated to help lessen other people’s suffering wherever possible. In her spare time, Saima likes to cook, bake, and watch medical dramas on television.
Sean Anselmo, BHSc, MDSA
Bioinformatic Data Analyst
Sean holds a Bachelor of Health Science (Honours) Specialization in Bioinformatics and a Master's in Data Science and Analytics, both from the University of Calgary.
Sean is knowledgeable in the field of genetics and is excited to work with novel precision medicine diagnostics. Sean has experience in medical genetics labs and transforming data into legible metrics. With expertise in computer science, genetics, and data science, he is interested in genome analysis and data aggregation.
He is motivated by the progress in Precision Medicine, and is passionate about bringing this technology to more people that need it.
In his spare time, Sean enjoys watching hockey, trips to the Alberta mountains, and spending time with his dog.
Dr. Alaknanda Dhotre, MD, MBA, RAQC, MA
Cancer Research Scientist And Regulatory Affairs Specialist
Dr. Alaknanda is a seasoned physician and researcher with over 16 years of experience in the fields of molecular bioscience, medicine, research and strategy in healthcare, pharma, medical devices, diagnostics, AI-ML applications, and regulatory affairs. She has worked with the USFDA, Health Canada, EMA, and Asian regulatory affairs and QMS.
She has completed her medical graduation (MD) from Seth G.S. Medical College and KEM Hospital, Mumbai; her Master's in Family Medicine from Christian Medical College (CMC) Vellore; her MBA and clinical trial certification from Johns Hopkins University, Baltimore, USA; and post-graduation work in regulatory affairs and quality control from Seneca College, Ontario, Canada, with President’s Honors. She has also done MA in English Literature with distinction from Mumbai University. She is an accomplished academic and a recipient of multiple gold medals.
At CTOAM, Dr. Alaknanda is responsible for supporting cancer genomic research at clinical and lab interface, research data analysis and report preparation, research publications, regulatory affairs and quality management system and business development.
She finds her role at CTOAM intellectually rewarding, as it provides continuous learning opportunities through the exploration of genomics – where each of the 20,813 genes offers unique insights. Dr. Alaknanda is particularly intrigued by the cutting-edge RNA genomic platform, recognizing its significant potential not only in cancer diagnostics and therapeutics but also across a broad range of other medical applications.
Outside of her professional pursuits, Dr. Alaknanda is an accomplished writer with two poetry book publications and English short stories and has received accolades in the field of literature. She is a trained singer and dancer, and loves reading, travelling, and exploring nature and different cultures.
Dr. Tara Kashkoulinejad Kouhi, PhD
Research Scientist
Tara is a scientist in life science with a multidisciplinary background. Born and raised in Iran, Tara earned her bachelor’s degree in genetics and advanced her expertise through a master’s and PhD in cellular and molecular biology, focusing on signaling pathways involved in cancer.
Tara spent two years as a visiting researcher in Spain, where she explored the field of nanobiotechnology, particularly its applications in gene delivery. In 2023, she moved to Canada to further her research as a postdoctoral fellow at Western University hospital, specializing in immunology. She thinks her multidisciplinary background enables her to play a pivotal role in optimizing cancer care for patients.
Outside of her professional pursuits, Tara enjoys exploring creative outlets and maintaining an active lifestyle. She has a passion for traveling and discovering new cultures. She also enjoys sharing her experiences through writing and reflection. Committed to personal well-being, Tara practices fitness routines and believes they help uplift her mentally.
Thrilled to be part of the CTOAM team, Tara believes that CTOAM provides a unique platform to combine cutting-edge science with compassionate care, helping her make a meaningful impact in the lives of those affected with cancer.
"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane
Discover how you can get better cancer treatment! Get your questions answered now
Get the latest advancements in cancer care delivered straight to your inbox each month!
Discover the newest, leading-edge advancements in cancer care...